SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
139.284 0.98 (0.71%)

NAV as on 31 Mar, 2015

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Feb 28, 15)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 94.74 24.37
Lupin Pharmaceuticals 57.65 14.83
Aurobindo Pharm Pharmaceuticals 36.30 9.34
Ranbaxy Labs Pharmaceuticals 32.01 8.23
Cadila Health Pharmaceuticals 23.22 5.97
Strides Arcolab Pharmaceuticals 21.94 5.64
Torrent Pharma Pharmaceuticals 21.43 5.51
Divis Labs Pharmaceuticals 15.49 3.98
Alembic Pharma Pharmaceuticals 10.90 2.80
Sequent Scienti Pharmaceuticals 9.68 2.49
Sector Allocation (Feb 28, 15)
  Sector   % 1-Year
High Low

Pharmaceuticals

91.57 99.60 91.57
Asset Allocation (%) (Feb 28, 15)
Class
%

Equity

91.57

Others / Unlisted

0.49

Debt

0.00

Mutual Funds

N.A

Money Market

8.71

Cash / Call

-0.77

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

62.74

Top 10

83.16
Sectors
%

Top 3

91.57
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.